Skip to content
Screener

Embecta Corp. EMBC Q3 2026 earnings

Reported August 7, 2026 · Before market open

Revenue$271.7MBeat by $17.2M
EPS$0.56Beat by $0.29
Revenue estimate$254.5M
EPS estimate$0.27
“Our third quarter results improved significantly on a sequential basis, with revenue increasing approximately $50 million, GAAP operating income increasing approximately $14 million, and adjusted operating income increasing approximately $21 million as compared to our second quarter results. The sequential increase was due to a combination of factors, including improved performance within the United States and International, as well as contribution from the acquisition of Owen Mumford which closed mid-way through our third quarter,
Management

Next report

Nov 24, 2026 (in 2 months)
Revenue estimate$269.7M
EPS estimate$0.31

Financials

Q3 2026

Income statement

See full
Revenue$271.7M-8.1%
Gross profit$153.3M-22.2%
Operating income$48.7M-48.2%
Net income$21.1M-53.6%
EPS (diluted)$0.36-53.8%

Balance sheet

See full
Cash & equivalents$218.2M-6.6%
Total debt$1.5B-1.0%
Total equity-$612.7M+8.5%
Total assets$1.3B+9.3%

Cash flow

See full
Operating cash flow$41.8M-48.5%
CapEx$1.1M+175%
Free cash flow$40.7M-49.6%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$290.66M-67.0%
Enterprise value$1.57B-27.3%
P/E3.3×-7.2×
P/S0.3×-0.5×

Profitability

See full
Gross margin59%-3.7pp
Operating margin21.9%+2.7pp
Net margin8.6%+1.0pp
FCF margin16.2%+4.2pp

Returns & leverage

See full
Current ratio1.7×-0.8×

Segments

By product

See full
Pen Needles$177.5M-18.2%
Safety$36.7M+5.5%
Syringes$36.6M+4.3%
Contract Manufacturing$5.3M-3.6%

FAQ

When did Embecta Corp. report Q3 2026 earnings?
Embecta Corp. (EMBC) reported Q3 2026 earnings on August 7, 2026 before market open.
What were Embecta Corp.'s Q3 2026 revenue and EPS?
Embecta Corp. reported revenue of $271.7M and eps of $0.56 for Q3 2026.
Did Embecta Corp. beat estimates in Q3 2026?
Revenue beat the consensus estimate of $254.5M by $17.2M. EPS beat the consensus estimate of $0.27 by $0.29.
How did Embecta Corp.'s Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 8.1% from $295.5M a year earlier and eps declined 50.0% from $1.12.
Where can I find Embecta Corp.'s Q3 2026 SEC filings?
You can read the 8-K earnings release (0001872789-26-000029) and the 10-Q periodic report (0001872789-26-000033) directly on SEC EDGAR. The filing index links above go to sec.gov.